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Abstract
Introduction: Vibro-acoustography (VA) is a recently developed imaging modality that is sensitive to the dynamic
characteristics of tissue. It detects low-frequency harmonic vibrations in tissue that are induced by the radiation
force of ultrasound. Here, we have investigated applications of VA for in vivo breast imaging.
Methods: A recently developed combined mammography-VA system for in vivo breast imaging was tested on
female volunteers, aged 25 years or older, with suspected breast lesions on their clinical examination. After
mammography, a set of VA scans was acquired by the experimental device. In a masked assessment, VA images
were evaluated independently by 3 reviewers who identified mass lesions and calcifications. The diagnostic
accuracy of this imaging method was determined by comparing the reviewers’ responses with clinical data.
Results: We collected images from 57 participants: 7 were used for training and 48 for evaluation of diagnostic
accuracy (images from 2 participants were excluded because of unexpected imaging artifacts). In total, 16
malignant and 32 benign lesions were examined. Specificity for diagnostic accuracy was 94% or higher for all 3
reviewers, but sensitivity varied (69% to 100%). All reviewers were able to detect 97% of masses, but sensitivity for
detection of calcification was lower (≤ 72% for all reviewers).
Conclusions: VA can be used to detect various breast abnormalities, including calcifications and benign and
malignant masses, with relatively high specificity. VA technology may lead to a new clinical tool for breast imaging
applications.
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Introduction
As a focus of intense research, breast cancer imaging
technology is evolving rapidly. For many years, mammo-
graphy has been the main tool used in breast imaging
and is the most widely used and recommended method.
The overall sensitivity of screening mammography for
women ranges from 51% to 66%; women younger than
40 years have lower detectability rates, predominantly
because of the greater density of breast tissue [1].
Conventional B-mode ultrasonography (US) is increas-
ingly used as an adjunct to mammography for breast ima-
ging; it improves sensitivity and has a considerable role in
detection of cysts and solid masses [2-6]. However, it is
still associated with a large number of false negative
results. The sensitivity of US for detecting ductal carci-
noma in situ is even lower than that of mammography,
which limits the usefulness of US as a screening test for
breast cancer [7,8].
Although magnetic resonance imaging (MRI) has
higher sensitivity compared with current breast imaging
methods, its lower specificity leads to unnecessary fol-
low-up examinations and biopsies. In addition, refusal
by some women to undergo MRI, the limited availability
and high cost are major constraints of breast MRI
[5,9,10].
To overcome the limitations of current breast ima-
ging tools, new tools for breast imaging and evaluation
must be developed. Ideally, such tools should have high
sensitivity and specificity, as well as being noninvasive,
capable of detecting microcalcifications, capable of
* Correspondence: alizad.azra@mayo.edu
1Department of Physiology and Biomedical Engineering, Mayo Clinic, 200
First Street SW, Rochester, MN 55905, USA
Full list of author information is available at the end of the article
Alizad et al. Breast Cancer Research 2012, 14:R128
http://breast-cancer-research.com/content/14/5/R128
© 2012 Alizad et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
imaging dense breast tissue, and available to a large
patient population at a reasonable cost. Significant
effort has been invested in the development and
improvement of breast imaging techniques, especially
those that provide palpation-like information, for
example, information about tissue stiffness. The ratio-
nale for such methods is the fact that breast lesions are
often stiffer than healthy tissue [11]; further, malignant
lesions are stiffer than benign lesions [12,13]. Examples
of imaging techniques that are sensitive to tissue stiff-
ness include magnetic resonance elastography [14,15],
US elastography [16-19], acoustic radiation force ima-
ging [20], and supersonic shear imaging (shear wave
elastography) [21].
Here, we present the applications of vibro-acousto-
graphy (VA) [22-26] in human breast imaging. Patients
with various types of breast masses and calcifications
were imaged, and the efficacy (diagnostic accuracy) of
the method was evaluated by comparing the responses
of multiple independent reviewers with clinical data.
Materials and methods
General principles of VA
VA measures the vibro-acoustic response of an object to
a vibrating force [25,26]. This method uses US in a way
that is fundamentally different from traditional US ima-
ging. VA harnesses the radiation force of US waves, a
minute force that is generated inside tissue, to remotely
vibrate tissue at a low frequency. The vibrations produce
a sound that can be detected by a hydrophone (a micro-
phone designed to receive sound through water or soft
tissues) and used to produce an acoustic image that
represents the object’s characteristics.
VA is sensitive to tissue dynamics and tissue stiffness.
Generally, VA images have high resolution (1 mm or
less) and are practically free of speckle noise [27]. VA
image resolution is a result of the focusing effect of US,
whereas the sensitivity to tissue dynamics is because tis-
sue vibration is a function of its overall stiffness and
damping. VA converts high-frequency US energy (MHz
range) to a low-frequency sound (kHz range). Therefore,
VA images can relay more information than traditional
US by displaying tissue properties at both ends of the fre-
quency spectrum. Preliminary work with an experimental
VA system has shown the feasibility of this approach in
various tissues [28-31].
Study subjects
Female volunteers (25 years or older), who had suspected
breast lesions on their clinical examination, were eligible
for the study. Pregnant women were excluded. The study
was conducted under a protocol approved by the Mayo
Clinic Institutional Review Board. Informed consent was
obtained as a part of the study protocol. Seven lesions
were categorized by the Breast Imaging-Reporting and
Data System (BI-RADS) as level 3, probably benign and
were therefore not biopsied. These lesions were stable on
short-term follow-up and did not require subsequent
biopsy. The rest of the lesions underwent ultrasound-
guided core needle biopsy. A 14-gauge cutting needle
was utilized. Five biopsy cores were obtained in each
case.
VA system
An experimental VA system, designed for in vivo breast
imaging, was used in this study. This system was inte-
grated into a clinical stereotactic mammography
machine (MammoTest system; Fischer Imaging, Inc,
Denver, Colorado, USA) so that matching VA and
mammography images (from the same view angle) could
be obtained for comparison. A schematic of the system
is shown in Figure 1. The system included a patient
examination bed, where the patient rested in a prone
position while her breast was passed through a hole in
the bed. The breast was placed between the back panel,
which included an x-ray detector, and a sliding panel
that kept the breast slightly compressed and secured for
mammography and VA scanning. The compression
panel included a window covered with a thin latex
membrane that was transparent to the US beam, and
the US transducer was located behind the window. VA
images were acquired in the cranial-caudal view at var-
ious depths from the skin. The VA image area was 5 ×
5 cm, and the breast typically was scanned in 0.2-mm
steps in either direction. Image resolution, which is
determined by the width of the US beam, was about 0.7
mm [23]. The hydrophone was placed on the side of the
breast to receive the acoustic emission generated by the
radiation force of US.
Figure 1 Schematic of the experimental combined
mammography and vibro-acoustic system shows the
positioning of the breast. The ultrasound (US) transducer and
hydrophone are moved out of x-ray path during mammography.
The compression panel has an 8 × 8-cm acoustic window covered
with a latex membrane. The 5 × 5-cm imaging area is within the
acoustic window.
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Reference image
We (the study authors) reviewed all data accrued from
each patient. The data included the mammograms
obtained during the experimental protocol, other available
clinical images such as clinical mammograms, US, and
MRI, and clinical data, such as palpation information,
from the patient record. Based on these data, the presence
of the abnormality and its shape and location in the ima-
ging window were determined. Images were reviewed to
ensure that the breast stayed in the same position during
mammography and VA image acquisition. The informa-
tion obtained in this review was used as a reference for the
blinded portion of the study.
Blinded review
Three independent reviewers were selected to participate
in a review of the VA images while masked to the patient
histories and clinical data. The reviewers were two radiol-
ogy residents and an assistant professor in biomedical
engineering who was familiar with VA techniques.
None of the reviewers had prior experience in interpreta-
tion of in vivo breast VA images. Because VA is a new
imaging modality, it was necessary to have the reviewers
undergo preliminary training to learn about VA and
familiarize themselves with the general appearance of
breast tissue, masses and calcification in a typical VA
image. They reviewed VA images of normal tissue and
benign and malignant lesions. For training purposes, the
VA images, corresponding mammograms, and clinical
and pathologic information from seven patients were
provided to all reviewers. These patient data were
excluded from the portion of the study that determined
the diagnostic accuracy of VA.
For the remaining VA images, each reviewer was asked
to identify mass lesions and calcifications in the image. No
other data were provided to the reviewers. Reviewers indi-
cated their confidence level in their identification by
selecting one of the following attributes: detected, not
detected, or inconclusive. To quantify the location, the
reviewers were asked to indicate the presence or absence
of possible masses or calcifications in five regions of the
image: center, upper left, upper right, lower left, and lower
right. Reviewers also judged the appearance of each
detected lesion and noted whether it was cancer, benign,
or inconclusive.
Data analysis
Diagnostic accuracy was assessed according to the princi-
ples of the Standards for the Reporting of Diagnostic
Accuracy initiative. Specifically, sensitivity and specificity
for each of the three blinded reviewers was assessed sepa-
rately (that is, stratified by reviewer). The 95% CIs for
binomial proportions are presented using the Score
method [32]. Two patients had bilateral scans, which
resulted in two observations per patient. However, because
of the randomization used during the blinded review, no
correlation of the results was anticipated or deemed biolo-
gically plausible. As such, the nesting of observations for
these patients was not considered essential and data were
analyzed as independent observations. Statistical analysis
was conducted using the SAS System 9.1.3 (SAS Institute,
Inc., Cary, NC, USA).
Role of the funding source
The sponsor was not involved in study design, data collec-
tion, analysis or interpretation of data, writing of the
report, or the decision to submit the paper for publication.
Results
In total, 64 women were recruited for the study. All
underwent clinical mammography before participating
in the study. Some patients also had breast US (n = 30),
MRI (n = 10), or both (n = 8) before the study. VA ima-
ging was attempted on all subjects; seven imaging
attempts failed because of various technical reasons, and
data from these patients were excluded from the study.
The data from another seven were used for training
purposes and were excluded from the blinded portion of
the study. Two additional cases (both patients with
fibroadenomas) were excluded from the blinded portion
of the study because of unacceptable image noise levels
(unknown cause). In sum, data from 48 patients were
available for analysis. Figure 2 summarizes the partici-
pant classifications and exclusions.
Diagnostic accuracy
Diagnostic accuracy was assessed by examining images
and detecting masses (either benign or malignant). Mass
detection was confirmed by having the reviewers indi-
cate the location of the mass on the image. Detection of
mass lesions (presence vs. absence) was uniformly high.
All reviewers correctly identified 37 of the 38 images
with a true mass lesion (sensitivity 97%, 95% CI 87%,
100%). All reviewers correctly located all true masses
except for one fibroadenoma (for that case, two
reviewers indicated the wrong location and one did not
detect a mass). Specificity for mass detection ranged
from 80% to 100%.
Detection of calcification was generally poor. Sensitiv-
ity for detecting calcium in the 25 positive images ran-
ged from 40% to 72%. However, when a calcified region
was identified by the reviewer, the image region also
was correct in all cases. Specificity for calcification
detection ranged from 83% to 87%.
In the 48 cases examined for diagnostic accuracy, 16
(33%) were classified as malignant cases (used to assess
sensitivity of the VA), and the remaining 32 cases were
classified as benign (used to assess specificity).
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Sensitivity estimates varied among reviewers (range 69%
to 100%). Specificity, however, was uniformly high
(≥ 94% for all reviewers) (Table 1).
Review of select cases
In this section, we present VA images of six cases and
compare VA imaging results with that of other imaging
modalities.
Case 1
The patient was a woman in her 70s. A screening mam-
mography showed scattered fibroglandular densities in
each breast and multiple bilateral mass lesions
(fibroadenoma).
The prone cranial-caudal mammogram of the right
breast showed a 2-cm, sharply marginated mass with
coarse lobulations of soft-tissue mass (Figure 3a).
Figure 2 Study flow diagram. Reference images were read by study authors, which included a radiologist. All patient data (for example, clinical
images, physical examination findings) were accessible for reference images. M, mass; mc, microcalcification; Rev, reviewer; Ref, reference.
Table 1 Diagnostic accuracy
Sensitivity (95% CI), % Specificity (95% CI), %
Reference Criterion Rev 1 Rev 2 Rev 3 Rev 1 Rev 2 Rev 3
Diagnosis
Malignant (n = 16) 100 (81,100) 69 (44,86) 69 (44,86) ... ... ...
Benign (n = 32) ... ... ... 97 (84,99) 94 (80,98) 97 (84,99)
Mass
Present (n = 38) 97 (87,100) 97 (87,100) 97 (87,100) ... ... ...
Absent (n = 10) ... ... ... 90 (60,98) 80 (49,94) 100 (72,100)
Calcification
Present (n = 25) 72 (52,86) 40 (23,59) 60 (41,77) ... ... ...
Absent (n = 23) ... ... ... 83 (63,93) 87 (68,95) 87 (68,95)
CI, confidence interval; Rev, reviewer.
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The fibroadenoma region was clearly seen in the
VA image, taken at a depth of 2.5 cm below the skin
(Figure 3b). The VA image identified the margins well,
including the gentle, coarse lobulations that are a classic
finding in fibroadenoma. The mammogram additionally
showed a well-circumscribed 3-mm calcification near the
mass, but it was out of focus in the VA image, owing to its
different depth.
The patient also had a calcified fibroadenoma in her left
breast. A mammogram of the left breast showed the calci-
fied mass (Figure 3c). The VA image clearly showed the
fibroadenoma (Figure 3d). This case demonstrates that VA
can identify calcified and noncalcified fibroadenoma.
Case 2
The patient was a woman in her 60s with invasive ductal
carcinoma, Nottingham grade II/III, in her right breast.
Screening and diagnostic mammography identified a
small group of suspicious microcalcifications of varying
sizes and shapes, and minimal architectural distortion
and increased soft-tissue density were noted (Figure 4a).
Targeted US confirmed a 5 × 7 hypoechoic lesion at the
12 o’clock position, with an irregular margin and poster-
ior shadowing. The VA image clearly showed a small
irregular mass with fine spiculation that is characteristic
of this type of malignant mass (Figure 4). The character-
istic spiculation was difficult to see in the mammogram.
Figure 3 Images from case 1. (A) Prone cranial-caudal mammogram of the right breast shows a well-defined mass (arrow). (B) Vibro-
acoustography (VA) imaging at the depth of 2.5 cm below the skin shows a well-defined mass (arrow). The slight upward shift was due to
patient movement after mammography. (C) Prone cranial-caudal mammogram of the left breast shows a 2-cm calcified mass (arrow). (D) VA
imaging at a depth of 2.5 cm shows the calcified mass (arrow). The slight upward shift was due to patient movement after mammography.
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This case demonstrates that VA can identify lesions with
architectural distortion (spiculation).
Case 3
The patient was a woman in her 40s with a palpable
lump in the right breast. A skin marker was placed dur-
ing mammography for correlation, but the mammogram
showed only the marker (that is, it failed to show the
lesion) because of extremely dense nodular parenchyma
(Figure 5a). An MRI scan showed an abnormal, 1-cm
ovoid, enhancing nodule that likely represented a fibroa-
denoma in the lower lateral region of the right breast,
4 cm from the nipple (Figure 5b). The nodule had an
angulated margin and slightly heterogeneous, low-level
internal echoes and was characterized as an indetermi-
nate lesion. The VA image of her breast at a 2.5-cm
depth (Figure 5c) and 3.0-cm depth (Figure 5d) showed
the lesion; it was at the same location as determined by
US and matched the marker placed during mammogra-
phy. Subsequent biopsy showed a papilloma with atypia.
This case demonstrates that VA can identify mammo-
graphically occult lesions in dense breast tissue.
Case 4
The patient was a woman in her 60s with grade I infil-
trating lobular carcinoma. She had mammographically
heterogeneous and dense parenchyma in both breasts.
A spiculated mass with no calcification was noted in
mammograms of the superior left breast (Figure 6a), with
skin retraction and thickening suggestive of malignancy.
Breast MRI identified a large, enhancing, irregular, spicu-
lated mass throughout the central left breast (Figure 6b),
with associated left breast shrinkage and nipple inversion.
The main mass measured approximately 8.5 × 3.3 × 5.4
cm. The mass extended laterally along the pectoralis
muscle. Breast VA of this patient also identified the
lesion, which extended beyond the 5 × 5-cm imaging
window, with remarkable spiculation suggestive of malig-
nancy (Figure 6c). This case demonstrates that VA can
identify breast cancer lesions.
Case 5
The patient was a woman in her 40s whose screening
mammography showed heterogeneous and dense breast
tissue. A diagnostic mammogram of the right breast
showed pleomorphic microcalcifications that were sug-
gestive of malignancy (Figure 7a). The VA image
showed the cluster of microcalcifications with greater
clarity (Figure 7b). The location of the calcification in
VA was shifted leftward because the patient moved her
arm after mammography, which caused the breast to
shift left within the imaging window of VA scanning.
The biopsy result indicated high-grade ductal carcinoma
in situ. Microcalcifications were present in malignant
ducts. This case demonstrates that VA can show clus-
ters of malignant microcalcifications.
Case 6
The patient was a woman in her 40s with a palpable mass
in her right breast. US examination showed a 29 × 19 ×
13-mm lobulated but well-defined, mildly hypoechoic
nodule with a slight increase in through-transmission.
Bilateral, digital, diagnostic mammography showed het-
erogeneous, dense, nodular parenchyma in both breasts.
The mammogram did not show the palpable mass. How-
ever, a marker was placed on the skin to identify the
Figure 4 Images from case 2. (A) Mammogram shows increased soft-tissue density with undefined border (arrow). (B) Vibro-acoustography at
a 2.0-cm depth shows an irregular mass with spiculation (arrow).
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Figure 5 Images from case 3. (A) Mammogram shows only a marker (arrow) placed on the site of the palpable mass (no mass visible in
image). (B) Magnetic resonance image shows the lesion (circle). (C-D) Vibro-acoustography images at a 2.5-cm depth (C) and 3.0-cm depth
(D) show the lesion (circles).
Figure 6 Images from case 4. (A) Mammogram shows a large distorted area with spiculation. The U-shaped wires are used to confirm image
orientation. (B) Magnetic resonance image shows a large, irregular, and spiculated region. The main mass measured approximately 8.5 × 3.3 ×
5.4 cm. (C) Vibro-acoustography image at a 2-cm depth shows a large spiculated mass. Note that figure parts (A) and (C) show only a 5 × 5-cm
area within the breast, whereas part (B) shows the entire breast.
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approximate location of the mass, as seen in the ultra-
sound (Figure 8a). The VA images indicated a round
mass with defined border and some lobulations inside
(Figure 8b and 8c). Pathologically, the mass was shown to
be a fibroadenoma. This case demonstrates that VA can
identify mass lesions not seen on mammograms.
Discussion
The main goal of this study was to assess the diagnostic
value of VA as a breast imaging tool. The initial results of
the blinded portion of the study showed that relatively
inexperienced reviewers could identify breast lesions with
high specificity. However, a number of factors must be
considered when interpreting these findings.
This was the first VA study of the human breast;
hence, the reviewers could have only limited experience
with various manifestations of breast lesions in a VA
scan. After VA is used with more clinical cases and
more information becomes available, skilled reviewers
could be recruited for future studies. We anticipate
greater experience will result in higher specificity and
sensitivity values.
Because of the small sample size, we limited lesion
classification to only two categories, benign and malig-
nant. However, each class can include various subcate-
gories with different image characteristics that, in some
cases, may overlap. We speculate that a larger sample
size could help improve classification and reduce errors.
The lack of speckle in VA compared with US is a con-
siderable advantage. This allows visualization of calcifica-
tions and other small details that may otherwise be lost in
a speckle-dominated US image [33].
The lesions that were identified had different contrast
to the surrounding tissues. In some cases the lesions
Figure 7 Images from case 5. (A) Mammogram shows microcalcifications that are suggestive of malignancy (arrow). (B) Vibro-acoustography
(VA) image at 2.5-cm depth shows a cluster of calcifications (arrow). The left shift of calcification was due to patient arm movement after
mammography and before VA scanning.
Figure 8 Images from case 6. (A) Mammogram shows only a marker placed in the vicinity of a palpable mass. (B-C) Vibro-acoustography
images of the same breast at 2.0-cm depth (B) and 2.5-cm depth (C) show a lobulated well-defined mass (arrows).
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appeared brighter than the surrounding tissue (Figures 3,
4, 6, and 7), while in others the lesion appeared darker
(Figures 5 and 8). Several factors contribute to the acous-
tic emission signal including the ultrasound reflectivity
and attenuation of the tissue as well as the mechanical
characteristics of the tissue at and around the focal
region at the difference frequency (Δf) [24-27]. Another
factor that influences the response of a targeted tissue is
its mechanical bonding to the surrounding tissues. The
calcifications such as those in Figures 3 and 7 can be
bright in the VA images because they are ultrasonically
highly reflective which may increase the radiation force
applied and cause the signal to increase. Soft tissue
lesions may appear darker or brighter than the surround-
ing tissues depending on their ultrasonic and mechanical
characteristics as well as their coupling to the surround-
ing tissue. The contrast that arises from these different
types of lesions is a topic of ongoing experimental and
theoretical research.
The VA system used in this study was a laboratory
system sufficient for proof-of-concept examinations and
exploration of the potential of VA in breast imaging. As
such, this system used a mechanical drive to move a
two-element transducer across the region of interest.
Clinical use of VA requires a more advanced design,
that is, a handheld probe with an array transducer cap-
able of fast electronic scanning. Development and eva-
luation of such a clinical system is already underway
[34,35]. We anticipate that this system will allow us to
collect more patient data and gauge the efficacy of
breast VA in clinical settings.
We acknowledge several limitations in this study. First,
the reference criterion was based on the overall clinical
impression and not pathologically confirmed diagnoses.
Pathology results were available for 41 participants; how-
ever, ascertainment of the results was influenced by clini-
cal impression and as such, use of the pathology results
would have resulted in verification bias (biopsy was not
performed in seven patients because the benignity of
those lesions was certain). Second, the sample size was
small and the resulting CIs were imprecise. Subsequent
study is required to refine the precision of the estimates
of diagnostic accuracy. Third, because the technology is
new, we had considerable variation in image interpreta-
tion among reviewers in the present study. This protocol
included seven cases for training purposes, but subse-
quent research should include more in-depth training.
We anticipate that a standardized training program will
decrease variation and that sensitivity will improve as
future studies are conducted with larger patient groups.
Clinically, VA may be of particular use when conven-
tional US findings are inconclusive. Further research
with a larger sample size is warranted to fully assess the
clinical value of this new imaging technique.
Conclusions
In vivo breast imaging by VA was performed on patients
with at least one breast mass. Images were evaluated by
inexperienced reviewers blinded to the clinical out-
comes. Sensitivity varied (depending on the target, for
example, calcification, masses, or diagnosis), but the
method generally demonstrated high enough diagnostic
accuracy to support further exploration of the clinical
value of VA in breast imaging.
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